Latest Articles

Publication Date
All News Scientific
First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central

First immunotherapy combination for endometrial cancer approved by NICE Oncology Central

Published: Aug. 6, 2025, 11:18 a.m.
Read Full Article
Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer - Oncology Nursing News

Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer Oncology Nursing News

Published: June 27, 2025, 6:10 p.m.
Read Full Article
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - BioSpace

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting BioSpace

Published: May 23, 2025, 5:55 a.m.
Read Full Article
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting - The Manila Times

Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting The Manila Times

Published: May 23, 2025, 12:24 a.m.
Read Full Article
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting The Manila Times

Published: May 22, 2025, 9:19 p.m.
Read Full Article
Genmab to Highlight New Data Evaluating Late-Stage Oncology - GlobeNewswire

Genmab to Highlight New Data Evaluating Late-Stage Oncology GlobeNewswire

Published: May 22, 2025, 9:06 p.m.
Read Full Article
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - Business Wire

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Business Wire

Published: May 22, 2025, 9:05 p.m.
Read Full Article
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - FinancialContent

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting FinancialContent

Published: May 22, 2025, 9:05 p.m.
Read Full Article
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025 - Morningstar

Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025 Morningstar

Published: May 20, 2025, 12:08 p.m.
Read Full Article
Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer - Oncology Nurse Advisor

Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer Oncology Nurse Advisor

Published: April 21, 2025, 4 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!